ReviewAlzheimer's & dementia : the journal of the Alzheimer's Association2020
Tackling challenges in care of Alzheimer's disease and other dementias amid the COVID-19 pandemic, now and in the future.
Review in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 94 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
94 citing papers in PubMed, 2 syntheses or guidelines pooled it, 200 citations in OpenAlex.
- Dementia is an age-independent risk factor for severity and death in COVID-19 inpatients.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2021Pooled it
- Non-pharmacological measures implemented in the setting of long-term care facilities to prevent SARS-CoV-2 infections and their consequences: a rapid review.The Cochrane database of systematic reviews · 2021Pooled it
- Brexpiprazole for agitation in clinically relevant patient subgroups: aCurrent medical research and opinion · 2025Trial
- Mortality Rates According to the Time of Onset of Mental Disorders Among Patients With Coronavirus Disease 2019 in South Korea: A Nationwide Retrospective Study.Psychiatry investigation · 2026Article
- COVID-19 infections in German long-term care facilities: a descriptive three-level analysis using claims and infection statistics data from October 2020 to March 2021.BMC public health · 2026Article
- Risk factors for 30-day COVID-19 mortality among people living with dementia in Alberta, Canada: a retrospective cohort study.BMC geriatrics · 2025Article
- The Effect of Psychological Resilience and Self-Efficacy on Caregiver Burden: A Cross-Sectional Study Among Caregivers of People With Alzheimer's Disease.Nursing open · 2025Article
- Expression of SARS-CoV-2 entry receptor ACE2 in human brain and its association with Alzheimer's disease and COVID-19.Molecular psychiatry · 2025Review
- Effects of Visitation Restriction on Antipsychotic Drug Use among Nursing Home Residents with ADRD during the COVID-19 Pandemic.Journal of the American Medical Directors Association · 2025Article
- Longitudinal trajectories of cognitive, functional, and neuropsychiatric decline in Alzheimer's disease during COVID-19 lockdown in South Korea.Scientific reports · 2025Article
- Coronavirus disease-2019 (COVID-19) outbreak in a long-term care hospital in Korea in early 2021.Infection prevention in practice · 2025Article
- SARS-CoV-2: A synergy to the Alzheimer's disease.Journal of neurovirology · 2025Review
- Mental and behavioral disorder mortality in Poland, 2000-2023: a national age-standardized Joinpoint regression study.Frontiers in public health · 2025Article
- Conventional and Emerging Drug Targeting Sites in Alzheimer's Disease and the Role of Translational Informatics in its Diagnosis and Management.Current neuropharmacology · 2025Review
- Bibliometric Analysis of COVID-19-related Publications in Nursing by Philippine-based Authors.Acta medica Philippina · 2025Article
- Risk factors for the neurodegenerative dementias in the Western Pacific region.The Lancet regional health. Western Pacific · 2024Review
- Article
- The 2022 symposium on dementia and brain aging in low- and middle-income countries: Highlights on research, diagnosis, care, and impact.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024Review
- The impact of COVID-19 on deaths from dementia and Alzheimer's disease in Chile: an analysis of panel data for 16 regions, 2017-2022.Lancet regional health. Americas · 2024Article
- Unveiling the sound of the cognitive status: Machine Learning-based speech analysis in the Alzheimer's disease spectrum.Alzheimer's research & therapy · 2024Article
34 more citing papers are in PubMed but not listed here.
Corrections and comments
- Erratum issuedErratum.2021
Authors and funding
35 authors at 20 institutions in 17 countries.
Funding
Abstract
We have provided an overview on the profound impact of COVID-19 upon older people with Alzheimer's disease and other dementias and the challenges encountered in our management of dementia in different health-care settings, including hospital, out-patient, care homes, and the community during the COVID-19 pandemic. We have also proposed a conceptual framework and practical suggestions for health-care providers in tackling these challenges, which can also apply to the care of older people in general, with or without other neurological diseases, such as stroke or parkinsonism. We believe this review will provide strategic directions and set standards for health-care leaders in dementia, including governmental bodies around the world in coordinating emergency response plans for protecting and caring for older people with dementia amid the COIVD-19 outbreak, which is likely to continue at varying severity in different regions around the world in the medium term.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.